Powered By
Metastatic breast, ++-, mets to bone, now liver. Just failed 2nd line of treatment, Ibrance, and fulvestrant.
Here's the basic info and a link to learn more about this Phase 3 Clinical Trial for HR+, Stage 3 or 4
for patients who have previously been treated with other chemo drugs:
Among the information provided is a tab to find where the clinical sites are that are participating.
What is Viktoria-1?
VIKTORIA-1 is a clinical trial for patients with HR+/HER2-, Stage 3 or 4 breast cancer who have already been treated with certain cancer drugs, including Ibrance ®, Kisqali ®, or Verzenio ®. The goal of this clinical trial is to evaluate a new investigational drug called gedatolisib by comparing it to currently available drug options for patients. In this trial, one group of participants will receive gedatolisib combined with Ibrance and fulvestrant, another group of participants will receive gedatolisib combined only with fulvestrant, and another group will receive available therapies according to certain biological features of their tumor. That’s where you come in.
Keeping you and all the participants in prayers!
Hugs!
While there aren't any specific experiences shared about the VIKTORIA 1 trial in the search results, it's helpful to understand what to generally expect in breast cancer clinical trials. Clinical trials typically run for months to years and require regular monitoring to measure how well the treatment is working.
The main Show Full Answer
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
